Welcome to our dedicated page for Pennantpark Invt SEC filings (Ticker: PNNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Digging through PennantPark Investment Corporation’s dense credit tables, valuation marks, and fee schedules can feel overwhelming, especially when each quarterly earnings report 10-Q filing exceeds a hundred pages. If you’ve ever wondered how to locate non-accrual loan details or track PennantPark Investment Corporation insider trading Form 4 transactions without spending hours, you’re not alone.
Stock Titan’s AI-powered analysis turns those problems into quick answers. Our platform streams every submission from EDGAR—whether it’s an 8-K about a material event, a proxy statement on executive compensation, or the annual report 10-K—within seconds of release. Then our algorithms translate legal jargon into plain language, flagging shifts in leverage ratios, dividend coverage, and loan ratings so you can focus on decisions, not deciphering disclosures.
Here’s what you can explore instantly:
- PennantPark Investment Corporation Form 4 insider transactions real-time, including executive stock transactions Form 4 alerts
- Line-by-line AI summaries of each PennantPark Investment Corporation quarterly earnings report 10-Q filing
- PennantPark Investment Corporation annual report 10-K simplified, with portfolio concentration and fee structure highlights
- PennantPark Investment Corporation proxy statement executive compensation details, broken down by base fees and incentive fees
- PennantPark Investment Corporation 8-K material events explained and cross-linked to related exhibits
Whether you’re monitoring credit quality shifts, comparing dividend sustainability, or simply understanding PennantPark Investment Corporation SEC documents with AI, our real-time dashboard delivers the insights professionals need. Skip the page-scrolling and move straight to informed analysis with Stock Titan.
Color Star Technology Co., Ltd. (NASDAQ: ADD) reported the results of its 29 June 2025 Annual General Meeting in a Form 6-K filing. Holders of 17,083,723 ordinary shares, representing 57.9 % of outstanding shares, formed a quorum and approved every agenda item.
Key resolutions:
- Reverse Share Split & Share Consolidation: Board may implement a reverse split at a ratio between 1-for-5 and 1-for-100. This reduces the share count and raises the par value while keeping authorised capital at US$32 million. Vote: 99.0 % in favour (16.92 m For / 0.16 m Against).
- Corporate Rebrand: Company name will change to Zeta Network Group. Vote: 99.3 % in favour (16.97 m For).
- Articles Amendment: Adoption of a Seventh Amended & Restated Memorandum and Articles to reflect the share consolidation and name change (99.3 % support).
- 2025 Equity Incentive Plan: Authorises new share-based awards; passed with 99.1 % support.
- Board Elections: Five directors (Wei Zhang, Hung-Jen Kuo, Honglei Jiang, Yan Zhang, Samantha Huang) re-elected with ~99.2 % approval each.
- Auditor Ratification: Assentsure PAC retained for FY 2025 (99.5 % approval).
- Routine filings and adjournment authorities also approved.
Implications for investors: The reverse split authority provides flexibility to lift a depressed share price or meet exchange listing requirements, but may compress existing shareholdings depending on the final ratio chosen. The equity plan could introduce dilution over time, while the rebrand signals a strategic repositioning. No financial performance metrics were disclosed in this filing.
Form 4 overview: Director Laura Berner of Bolt Biotherapeutics (BOLT) reported a single equity-based transaction dated May 27 2025. She received a non-qualified stock option for 1,100 common shares at an exercise price of $6.40 per share. All figures give effect to the 1-for-20 reverse stock split that the company executed on June 6 2025.
Key terms of the grant:
- Vesting: Options vest on the earlier of May 27 2026 or the day immediately prior to the next annual meeting, subject to continued service.
- Change-in-control: The award vests in full upon a change-in-control event.
- Expiration: May 26 2035 (10-year life).
No shares were purchased or sold; the filing reflects compensation-related option issuance. Post-grant, Berner beneficially owns 1,100 derivative securities and no disclosed non-derivative common shares.
Corporate context: The recent reverse split consolidated each 20 common shares into one, reducing the share count and proportionally increasing exercise prices. Prior to the split, the grant was for 22,000 shares at $0.32 per share. The filing provides no additional financial or operational data.
FAQ
What is the current stock price of Pennantpark Invt (PNNT)?
What is the market cap of Pennantpark Invt (PNNT)?
What is the primary business of PennantPark Investment Corp?
How does the company generate revenue?
What distinguishes PennantPark Investment Corp in the competitive landscape?
What types of investments does PennantPark employ?
What market segment does the company target?
How does PennantPark approach risk management?
Who are the typical beneficiaries of its capital solutions?
What expertise does the management team bring to the company?
